Medically reviewed on Nov 1, Lipid-altering agents should be 6mg in addition to a diet restricted in saturated fat and cholesterol when click to see more to diet and nonpharmacological crestor treatment 6mg alone has been inadequate.
Crestor is indicated as adjunctive therapy to diet for the treatment of adult patients with /quitting-zoloft-25-mg-cold-turkey.html. Crestor is indicated as adjunctive therapy crestor treatment 6mg other lipid-lowering treatments e.
The usual starting dose in crestor treatment 6mg patients with homozygous familial hypercholesterolemia is 20 mg once daily.
The maximum Crestor dose of 40 mg should be used only for those patients who crestor treatment 6mg not achieved their LDL-C goal utilizing the 20 mg dose [see Warnings and Precautions 5.
Crestor can be administered crestor treatment 6mg a single dose at any time of crestor treatment 6mg, with or without food.
The tablet 6mg be swallowed whole. In heterozygous familial crestor treatment 6mg, the recommended dose range is 5 to 10 mg orally once daily in patients 8 crestor treatment 6mg less than 10 years of crestor treatment 6mg, and 5 to 20 mg orally once daily in patients 10 to 17 years of age. In homozygous familial hypercholesterolemia, the recommended dose is 20 mg orally once daily in patients 7 crestor treatment 6mg /strattera-reviews-for-depression-moms.html years of age.
The dose of Crestor should not crestor treatment 6mg 5 mg crestor treatment 6mg daily [see Warnings and Precautions 5. Avoid concomitant use of Crestor with gemfibrozil.
If concomitant use cannot be avoided, initiate Crestor at 5 mg once daily.
The dose of Crestor should not exceed 10 mg once daily [see Warnings and Precautions 5. Patients taking atazanavir and ritonavir, lopinavir and ritonavir, or simeprevir.
Initiate Crestor therapy with 5 mg once crestor treatment 6mg. Yellow, round, biconvex, coated tablets. Pink, round, crestor treatment 6mg, coated tablets. Pink, oval, biconvex, coated tablets. Cases of myopathy and rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported with HMG-CoA reductase inhibitors, including Crestor.
crestor treatment 6mg Crestor should be prescribed with caution in patients with predisposing factors crestor treatment 6mg myopathy e.
Cases of myopathy, including rhabdomyolysis, have been 6mg with 6mg reductase inhibitors, crestor treatment 6mg rosuvastatin, coadministered with colchicine, and caution should be exercised when prescribing Crestor with colchicine [see Drug Interactions 7. Crestor therapy should be discontinued if markedly elevated creatine kinase levels occur or myopathy is diagnosed or suspected. Crestor therapy should also be temporarily withheld in any patient with an acute, serious condition suggestive of myopathy or predisposing to the development of renal failure secondary crestor treatment 6mg rhabdomyolysis e.
There have been rare reports of immune-mediated necrotizing myopathy IMNMan 6mg myopathy, associated with statin use. IMNM is characterized by: All 6mg crestor treatment 6mg be advised to promptly report to their physician unexplained crestor treatment 6mg pain, tenderness, or weakness, crestor treatment if accompanied by malaise or fever or if muscle signs and symptoms persist after discontinuing Crestor.
It is recommended that liver enzyme tests be performed before the initiation of crestor treatment 6mg href="/depakote-iv.html">/depakote-iv.html, and if signs or symptoms of liver injury occur. In most cases, crestor treatment 6mg elevations were transient and resolved or improved on continued therapy or after a brief interruption in therapy.
There were two cases of jaundice, for which a relationship to Crestor therapy could crestor treatment 6mg be determined, which resolved after discontinuation of therapy.
There were no cases of liver failure or irreversible liver go here in these trials. There have been rare postmarketing reports of fatal and crestor treatment 6mg hepatic failure in patients taking statins, including rosuvastatin. If an alternate crestor treatment 6mg is not found, do not restart Crestor.
Active liver disease, which may include unexplained persistent transaminase elevations, is a contraindication to the use of Crestor [see Contraindications 4 ]. Crestor treatment patients taking coumarin anticoagulants and Crestor concomitantly, 6mg should be determined before starting Crestor and frequently 6mg during early therapy article source ensure that no significant alteration of INR occurs [see Drug Interactions 7.
In the Crestor clinical trial program, dipstick-positive proteinuria and microscopic hematuria were observed among Crestor crestor treatment 6mg patients.
2018 ©